Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,152 | -7,987 | -2,814 | N/A |
| Depreciation Amortization | 37 | 555 | 107 | N/A |
| Income taxes - deferred | N/A | 43 | -43 | N/A |
| Accounts payable and accrued liabilities | 15 | 127 | 26 | N/A |
| Other Working Capital | 226 | 227 | 102 | N/A |
| Other Operating Activity | 3,345 | 5,524 | 2,543 | 0 |
| Operating Cash Flow | $-1,530 | $-1,512 | $-79 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -130 | -105 | N/A | N/A |
| PPE Investments | -29 | -57 | N/A | N/A |
| Net Acquisitions | N/A | N/A | 3 | N/A |
| Other Investing Activity | 0 | -3 | 0 | 0 |
| Investing Cash Flow | $-159 | $-165 | $3 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 1,117 | 123 | N/A |
| Debt Repayment | 238 | N/A | N/A | N/A |
| Common Stock Issued | 1,110 | 923 | N/A | N/A |
| Financing Cash Flow | $1,348 | $2,040 | $123 | $N/A |
| Beginning Cash Position | 409 | 47 | N/A | N/A |
| End Cash Position | 69 | 409 | 47 | N/A |
| Net Cash Flow | $-340 | $362 | $47 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,530 | -1,512 | -79 | N/A |
| Capital Expenditure | -29 | -57 | N/A | N/A |
| Free Cash Flow | -1,559 | -1,569 | -79 | 0 |